RZLT
RezoluteDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
RZLT vs peer average
46/100
RZLT vs. peer average (D vs. D)
Grade spread
B 1 · C 4 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
RNAC is the first available peer comparator.
Cartesian is another loose clinical-stage biotech comp with binary data sensitivity, but its modality and disease focus differ materially from Rezolute's HI program.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RZLT
Rezolute
RNAC
Cartesian Therapeutics
Grade
D
C
Momentum
54
12
Value
41
41
Sentiment
43
70
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs RNAC
RZLT / RNAC
Grade Position
In line
RZLT vs. peer average (D vs. D)
46/100
Momentum
54
RZLTValue
41
RZLTSentiment
43
RNACRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RZLT
RNAC is the first peer returned for this comparison set.